Endorepellin, a Novel Inhibitor of Angiogenesis Derived from the C Terminus of Perlecan

This publication has 74 references indexed in Scilit:

• Fibroblast Growth Factor-binding Protein Is a Novel Partner for Perlecan Protein Core
  Journal of Biological Chemistry, 2001
• Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity
  Journal of Molecular Biology, 2000
• Interaction of skeletal muscle cells with collagen type IV is mediated by perlecan associated with the cell surface
  Journal of Cellular Biochemistry, 1999
• Structural basis of glycosaminoglycan modification and of heterotypic interactions of perlecan domain V 1 1Edited by I. B. Holland
  Journal of Molecular Biology, 1999
• Localization of Glycosaminoglycan Substitution Sites on Domain V of Mouse Perlecan
  Biochemical and Biophysical Research Communications, 1999
• Endostatin Binds to Blood Vessels in Situ. Independent of Heparan Sulfate and Does Not Compete for Fibroblast Growth Factor-2 Binding
  The American Journal of Pathology, 1999
• Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo.
  Journal of Clinical Investigation, 1998
• Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
  Published by Elsevier ,1996
• Perlecan in human bone marrow: A growth-factor-presenting, but anti-adhesive, extracellular matrix component for hematopoietic cells
  Matrix Biology, 1995
• Proteoglycans of basement membranes
  Cellular and Molecular Life Sciences, 1993